This article has been updated to include comments from WaferGen's conference call following the release of results.


NEW YORK (GenomeWeb) - WaferGen Biosystems reported after the close of the market Wednesday that its second quarter revenues fell 6 percent due to reduced SmartChip capital equipment sales.

For the three months ended June 30, the genetic analysis products maker reported total revenues of $1.6 million, compared to $1.7 million in Q2 2014 and short of the consensus analysts' estimate of $2.1 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The World Health Organization has announced the members of its gene-editing committee, according to NPR.

DARPA is working on developing algorithms that gauge the credibility of research findings, Wired reports.

The American Society of Breast Surgeons recommends all women diagnosed with breast cancer be offered genetic testing, the Washington Post says.

In Science this week: comparison of modern, historical rabbit exomes uncovers parallel evolution after myxoma virus exposure; and more.